Mr. Kofi Nsiah-Poku

Mr. Kofi Nsiah-Poku is the MANAGING DIRECTOR of Kinapharma Limited. Kofi Nsiah-Poku is an entrepreneur who has grown his Ghana-based companies into successful enterprises on an international level. Kinapharma is a leading producer and seller of a variety of over the counter pharmaceuticals in Ghana, Nigeria, Sierra Leone and Liberia. Healthilife Beverages is a celebrated brand among Ghanians for its juices and milk products that are popular with children and adults. Nsiah-Poku annually supports numerous charities especially relating to sports, health, education and Christian outreach.

 

In the last decade, Kofi has taken several bold diversification initiatives and massively increased his footprints, setting up Xpert security Ltd to offer cutting-edge electronic security solutions including Intruder Detection Systems, electronic surveillance and vehicle tracking to blue chip multinational companies, diplomatic missions and luxury real estate complexes across the country. Green Diamond Estates was the next venture a few years later, engaged in the building and managing of multi-unit high end full-service residential enclaves including Aspect Court. Kofi’s most recent venture is HealthiLife Beverages Ltd. with a spec built and managed Tetra Pak food processing facility which has quickly created and established relished juice, milk and energy drink brands including Go! Xtra, Pure Milk and Gluconade. The HealthiLife plant is also already a contract manufacturing concern for some of the world’s biggest multinational drink brands. To date HealthLife remains arguably the largest indigenous privately owned and managed food manufacturing facility built at an estimated 40 million dollars. The facility, too big for just the local market, now has offices and distribution throughout West Africa including Nigeria, Liberia and Sierra Leone and counting. Intensely engaged personally in the initiatives, direction and leadership of his business, Kofi brings his calm, persistent, constantly-learning self to bear on all the businesses. His steady hands direct these businesses that are built to last from the current direct staff strength of over a thousand to businesses with unlimited potential.

Mr. Madhusudan Agrawal

Mr. Madhusudan Agrawal is the Co-Founder & Vice Chairman of  Ajanta Pharma Ltd. Mr Madhusudan Agrawal co-founded Ajanta Pharma Limited, took charge of its exports and expanded the company to over 30 countries. He has achieved great heights in all spheres of life – business, social or personal. Mr Agrawal started with a singular objective to serve global healthcare needs through empathy, innovation and technology. His vision was not only to make an organisation of repute but also to fulfil the unmet medical needs of the suffering poor.

 

Mr Agarwal has been conferred with several awards by various businesses, social organisations and government agencies. The Government of Uganda has also appointed him as “Honorary Consul” in Mumbai for Western India. Ajanta Pharma Limited is a pharmaceutical company involved in the areas of product research, manufacturing, and marketing. The Company’s manufacturing capabilities include segments such as antiretrovirals, antimalarials, cardiovascular, dermatology, and ophthalmology. The Company also markets over the counter products that include some nature-based remedies.

Mr. Sano Yoshihiko

Mr.Yoshihiko Sano holds the position of President & Representative Director at Nipro Corp & He is also on the board of Sanri Kosan Co., Ltd. Mr. Yoshihiko Sano has worked as an architect since he graduated from Tokyo University of Science with the degrees of Bachelor of Engineering (Architecture) in 1979 and Master of Engineering (Architecture) in 1981. He worked in the design department of the Takenaka Corporation until 1986 when he joined Yasui Architects & Engineers, Inc. He was elevated to President/Principal Architect at Yasui Architects & Engineers in 1997. In addition to his position as a leading architect and business leader, Yoshihiko is a respected force in the Japan Institute of Architects (JIA) and its relationship with the AIA. He became admitted to Honorary Fellowship AIA in 2016. Besides, he is an excellent and passionate academic teacher of architecture, and he encourages aspiring students with a sincere and earnest manner.He received awards including the following: Minister of Land, Transport and Tourism Award in 2011 and the Prize of Architectural Institute of Japan in 2019.

 

Since its founding in 1954, Nipro Corporation has strived to realize its management philosophy of contributing to society through its business activities. The Company has expanded the scope of its business from medical glass products to medical devices and pharmaceutical products, in pursuit of technological innovation. Leveraging the technologies and expertise that we have accumulated over many years, the Company now offers products and technologies that meet the needs of patients and medical professionals in a wide range of fields, such as artificial organs, circulatory organs, test/diagnostic agents, injection/infusion solutions, ethical pharmaceuticals, and pharmapackaging products. Our strongest feature is the “trinity” of the medical device, pharmaceutical, and pharmapackaging businesses, which work in unison to generate synergies in our operations.